EurekaMag.com logo
+ Site Statistics
References:
54,215,046
Abstracts:
30,230,908
PMIDs:
28,215,208
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Comparative effectiveness of griseofulvin and nizoral therapy in patients with onychomycoses



Comparative effectiveness of griseofulvin and nizoral therapy in patients with onychomycoses



Vestnik Dermatologii i Venerologii (3): 47-50



Griseofulvin and nisoral therapy was administered to 203 onychomycosis patients. Nisoral proved more effective: clinical cure was achieved in 98.5 percent of patients sooner than in those treated with griseofulvin. A lower incidence of side effects is another advantage of nisoral.

(PDF emailed within 1 workday: $29.90)

Accession: 007134292

Download citation: RISBibTeXText



Related references

Comparative efficacy of griseofulvin and Nizoral therapy in patients with onychomycoses. Vestnik Dermatologii i Venerologii ( 3): 47-50, 1991

Therapy of onychomycoses with griseofulvin. Arch Union Med Balkan 2(5/6): 609-610, 1964

Results Of Griseofulvin Therapy Of Onychomycoses. (Contribution To Local Therapy). Zeitschrift für Haut- und Geschlechtskrankheiten 38: 99-107, 1965

Combined treatment of onychomycoses with griseofulvin in combination with topical therapy. Vestnik Dermatologii i Venerologii 40(1): 46-49, 1966

Continuous or discontinuous therapy of onychomycoses with resorption active griseofulvin?. Mykosen. 9: 3, 126-129, 1966

Mold And Yeast Infections As A Cause In Failures In Griseofulvin Therapy Of Onychomycoses. Vestnik Dermatologii i Venerologii 38: 60-61, 1964

Combined assessment of blood neutrophil phagocytic activity in rubrophytosis patients treated with griseofulvin and Nizoral. Vestnik Dermatologii i Venerologii ( 1): 50-52, 1989

A comprehensive assessment of the phagocytic activity of the blood neutrophils in patients with rubromycosis treated with griseofulvin and nizoral. Vestnik Dermatologii i Venerologii: 50-52, 1989

A combined assessment of blood neutrophil phagocytic activity in rubrophytosis patients treated with griseofulvin and nizoral. Vestnik Dermatologii i Venerologii (1): 50-52, 1989

Control methods in the griseofulvin treatment of patients with systemic onychomycoses. Vest. Derm. Vener, 52: 6, 40-44, 1968

Results Of Long-Term Treatment Of Onychomycoses With Griseofulvin. Report On 5-Year Experiences With Conservative Therapy. Zeitschrift für Haut- und Geschlechtskrankheiten 38: 399-408, 1965

Griseofulvin in tineas and onychomycoses. Archives Belges de Dermatologie et de Syphiligraphie 16: 408-412, 1960

On intermittent griseofulvin treatment of onychomycoses. Journal of Educational Psychology 57(2): 2027-2034, 1966

Terbinafine vs griseofulvin in the treatment of onychomycoses due to dermatophytes. Giornale Italiano di Dermatologia e Venereologia 129(4): XIX-XXII, 1994

Catamnestic studies of onychomycoses treated with griseofulvin. Mykosen. 9: 5, 179-203, 1966